Sildenafil treatment (Homo sapiens)

From WikiPathways

Description

Quality Tags

Ontology Terms

Saving...

Bibliography

1. Lario PI, Bobechko B, Bateman K, Kelly J, Vrielink A, Huang Z; ''Purification and characterization of the human PDE4A catalytic domain (PDE4A330-723) expressed in Sf9 cells.''; Arch Biochem Biophys, 2001 PubMed Europe PMC Scholia
2. Livi GP, Kmetz P, McHale MM, Cieslinski LB, Sathe GM, Taylor DP, Davis RL, Torphy TJ, Balcarek JM; ''Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase.''; Mol Cell Biol, 1990 PubMed Europe PMC Scholia
3. Taherzadeh-Fard E, Saft C, Akkad DA, Wieczorek S, Haghikia A, Chan A, Epplen JT, Arning L; ''PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease.''; Mol Neurodegener, 2011 PubMed Europe PMC Scholia
4. Giuili G, Scholl U, Bulle F, Guellaen G; ''Molecular cloning of the cDNAs coding for the two subunits of soluble guanylyl cyclase from human brain.''; FEBS Lett, 1992 PubMed Europe PMC Scholia
5. Zabel U, Weeger M, La M, Schmidt HH; ''Human soluble guanylate cyclase: functional expression and revised isoenzyme family.''; Biochem J, 1998 PubMed Europe PMC Scholia
6. Zembowicz A, Hecker M, Macarthur H, Sessa WC, Vane JR; ''Nitric oxide and another potent vasodilator are formed from NG-hydroxy-L-arginine by cultured endothelial cells.''; Proc Natl Acad Sci U S A, 1991 PubMed Europe PMC Scholia
7. Sporbert A, Mertsch K, Smolenski A, Haseloff RF, Schonfelder G, Paul M, Ruth P, Walter U, Blasig IE; ''Phosphorylation of vasodilator-stimulated phosphoprotein: a consequence of nitric oxide- and cGMP-mediated signal transduction in brain capillary endothelial cells and astrocytes.''; Brain Res Mol Brain Res, 1999 PubMed Europe PMC Scholia
8. Luna-Medina R, Cortes-Canteli M, Sanchez-Galiano S, Morales-Garcia JA, Martinez A, Santos A, Perez-Castillo A; ''NP031112, a thiadiazolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role in brain disorders.''; J Neurosci, 2007 PubMed Europe PMC Scholia
9. Bird MJ, Thorburn DR, Frazier AE; ''Modelling biochemical features of mitochondrial neuropathology.''; Biochim Biophys Acta, 2014 PubMed Europe PMC Scholia
10. Diaz B, Serna J, De Pablo F, de la Rosa EJ; ''In vivo regulation of cell death by embryonic (pro)insulin and the insulin receptor during early retinal neurogenesis.''; Development, 2000 PubMed Europe PMC Scholia
11. Rivero-Vilches FJ, de Frutos S, Saura M, Rodriguez-Puyol D, Rodriguez-Puyol M; ''Differential relaxing responses to particulate or soluble guanylyl cyclase activation on endothelial cells: a mechanism dependent on PKG-I alpha activation by NO/cGMP.''; Am J Physiol Cell Physiol, 2003 PubMed Europe PMC Scholia
12. Takimoto E, Champion HC, Belardi D, Moslehi J, Mongillo M, Mergia E, Montrose DC, Isoda T, Aufiero K, Zaccolo M, Dostmann WR, Smith CJ, Kass DA; ''cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.''; Circ Res, 2005 PubMed Europe PMC Scholia
13. Schmidt HH, Murad F; ''Purification and characterization of a human NO synthase.''; Biochem Biophys Res Commun, 1991 PubMed Europe PMC Scholia
14. Galera-Monge T, Zurita-Diaz F, Canals I, Hansen MG, Rufian-Vazquez L, Ehinger JK, Elmer E, Martin MA, Garesse R, Ahlenius H, Gallardo ME; ''''; , PubMed Europe PMC Scholia
15. Jacquin MA, Chiche J, Zunino B, Beneteau M, Meynet O, Pradelli LA, Marchetti S, Cornille A, Carles M, Ricci JE; ''GAPDH binds to active Akt, leading to Bcl-xL increase and escape from caspase-independent cell death.''; Cell Death Differ, 2013 PubMed Europe PMC Scholia
16. Cohen MM Jr; ''''; , PubMed Europe PMC Scholia
17. Hartell NA; ''cGMP acts within cerebellar Purkinje cells toproduce long term depression via mechanisms involving PKC and PKG.''; Neuroreport, 1994 PubMed Europe PMC Scholia
18. Laine J, Kunstle G, Obata T, Sha M, Noguchi M; ''The protooncogene TCL1 is an Akt kinase coactivator.''; Mol Cell, 2000 PubMed Europe PMC Scholia
19. Virbasius JV, Scarpulla RC; ''Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis.''; Proc Natl Acad Sci U S A, 1994 PubMed Europe PMC Scholia
20. Furchgott RF, Vanhoutte PM; ''Endothelium-derived relaxing and contracting factors.''; FASEB J, 1989 PubMed Europe PMC Scholia
21. Blount MA, Beasley A, Zoraghi R, Sekhar KR, Bessay EP, Francis SH, Corbin JD; ''Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.''; Mol Pharmacol, 2004 PubMed Europe PMC Scholia
22. Zhan X, Li D, Johns RA; ''Immunohistochemical evidence for the NO cGMP signaling pathway in respiratory ciliated epithelia of rat.''; J Histochem Cytochem, 1999 PubMed Europe PMC Scholia
23. Owada Y, Utsunomiya A, Yoshimoto T, Kondo H; ''Expression of mRNA for Akt, serine-threonine protein kinase, in the brain during development and its transient enhancement following axotomy of hypoglossal nerve.''; J Mol Neurosci, 1997 PubMed Europe PMC Scholia
24. Chung HH, Dai ZK, Wu BN, Yeh JL, Chai CY, Chu KS, Liu CP, Chen IJ; ''''; , PubMed Europe PMC Scholia
25. Loughney K, Hill TR, Florio VA, Uher L, Rosman GJ, Wolda SL, Jones BA, Howard ML, McAllister-Lucas LM, Sonnenburg WK, Francis SH, Corbin JD, Beavo JA, Ferguson K; ''Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3',5'-cyclic nucleotide phosphodiesterase.''; Gene, 1998 PubMed Europe PMC Scholia
26. Goffart S, Wiesner RJ; ''Regulation and co-ordination of nuclear gene expression during mitochondrial biogenesis.''; Exp Physiol, 2003 PubMed Europe PMC Scholia
27. Stevic N, Maalouf J, Argaud L, Gallo-Bona N, Lo Grasso M, Gouriou Y, Gomez L, Crola Da Silva C, Ferrera R, Ovize M, Cour M, Bidaux G; ''Cooling Uncouples Differentially ROS Production from Respiration and Ca²⁺Homeostasis Dynamic in Brain and Heart Mitochondria.''; Cells, 2022 PubMed Europe PMC Scholia
28. Scott JD; ''Cyclic nucleotide-dependent protein kinases.''; Pharmacol Ther, 1991 PubMed Europe PMC Scholia
29. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ; ''''; , PubMed Europe PMC Scholia
30. Olson BL, Hock MB, Ekholm-Reed S, Wohlschlegel JA, Dev KK, Kralli A, Reed SI; ''SCFCdc4 acts antagonistically to the PGC-1alpha transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis.''; Genes Dev, 2008 PubMed Europe PMC Scholia
31. Beltman J, Becker DE, Butt E, Jensen GS, Rybalkin SD, Jastorff B, Beavo JA; ''''; , PubMed Europe PMC Scholia
32. Kunstle G, Laine J, Pierron G, Kagami Si S, Nakajima H, Hoh F, Roumestand C, Stern MH, Noguchi M; ''Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1.''; Mol Cell Biol, 2002 PubMed Europe PMC Scholia
33. Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C; ''Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesteraseinhibitor for the treatment of penile erectile dysfunction.''; Int J Impot Res, 1996 PubMed Europe PMC Scholia
34. Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, Troconso JC, Dawson VL, Dawson TM; ''''; , PubMed Europe PMC Scholia
35. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD; ''''; , PubMed Europe PMC Scholia
36. Borniquel S, Valle I, Cadenas S, Lamas S, Monsalve M; ''Nitric oxide regulates mitochondrial oxidative stress protection via the transcriptional coactivator PGC-1alpha.''; FASEB J, 2006 PubMed Europe PMC Scholia

History

External references

DataNodes

Name	Type	Database reference	Comment
AKT1	GeneProduct	ENSG00000142208 (Ensembl)
AKT2	GeneProduct	ENSG00000105221 (Ensembl)
AKT3	GeneProduct	ENSG00000117020 (Ensembl)
AMP	Metabolite	CHEBI:16027 (ChEBI)
Calcium homeostasis	Pathway	WP4088 (WikiPathways)
GAPDH inhibitors	Metabolite	CHEBI:70817 (ChEBI)
GAPDH	GeneProduct	ENSG00000111640 (Ensembl)
GMP	Metabolite	CHEBI:17345 (ChEBI)
GSK3B	GeneProduct	ENSG00000082701 (Ensembl)
GTP	Metabolite	CHEBI:37565 (ChEBI)
GUCY1A1	GeneProduct	ENSG00000164116 (Ensembl)	Also known as GUCY1A3 [uniprot:Q02108].
GUCY1A2	GeneProduct	ENSG00000152402 (Ensembl)
GUCY1B1	GeneProduct	ENSG00000061918 (Ensembl)	Also known as GUCY1B3 [uniprot:Q02153].
GUCY1B2	GeneProduct	ENSG00000123201 (Ensembl)
MAPK pathway	Pathway	WP382 (WikiPathways)
Mitochondrial biogenesis	Pathway	WP3331 (WikiPathways)
Mitochondrial membrane potential	Pathway	R-HSA-8949215 (Reactome)
NO-signaling	Pathway	WP1850 (WikiPathways)
NOS1	GeneProduct	ENSG00000089250 (Ensembl)
NOS2	GeneProduct	ENSG00000007171 (Ensembl)
NOS3	GeneProduct	ENSG00000164867 (Ensembl)	NOS3 is implicated in vascular smooth muscle relaxation through cGMP [PMID:1378832,PMID:20590592].
NRF1	GeneProduct	ENSG00000106459 (Ensembl)
Neurogenesis	Pathway	R-HSA-9675108 (Reactome)
Nitric oxide	Metabolite	CHEBI:16480 (ChEBI)
OXPHOS capacity	Pathway	WP111 (WikiPathways)
PDE4 inhibitors	Metabolite	CHEBI:68844 (ChEBI)
PDE4A	GeneProduct	ENSG00000065989 (Ensembl)
PDE4B	GeneProduct	ENSG00000184588 (Ensembl)
PDE4C	GeneProduct	ENSG00000105650 (Ensembl)
PDE4D	GeneProduct	ENSG00000113448 (Ensembl)
PDE5	GeneProduct	ENSG00000138735 (Ensembl)	Inhibition of cGMP degradation by PDE5 increases cGMP availability [PMID:9714779].
PI3K Cascade	Pathway	WP4448 (WikiPathways)	AKT is activated through phosphorylation upon recruitement to the cell membrane
PPARGC1A	GeneProduct	ENSG00000109819 (Ensembl)	Alternative name is PGC1A [uniprot:Q9UBK2]
PRKG1	GeneProduct	ENSG00000185532 (Ensembl)
PRKN	GeneProduct	ENSG00000185345 (Ensembl)
Smooth muscle relaxation	Pathway	R-HSA-418457 (Reactome)
Synaptic transmission	Pathway	R-HSA-112310.5 (Reactome)
TFAM	GeneProduct	ENSG00000108064 (Ensembl)
ZNF746	GeneProduct	ENSG00000181220 (Ensembl)
cGMP	Metabolite	CHEBI:16356 (ChEBI)
sildenafil	Metabolite	CHEBI:9139 (ChEBI)
tideglusib	Metabolite	CHEBI:147398 (ChEBI)

Annotated Interactions

Source	Target	Type	Database reference	Comment
AKT	Mitochondrial membrane potential	Arrow	R-HSA-04151 (Reactome)	The family of AKT proteins stabalize mitochondrial membrane potential through TCL1A [uniprot:P56279] and TCL1B [unirprot:O95988]. [PMID:10983986,PMID:11839817]
AKT	Neurogenesis	Arrow	R-HSA-157118 (Reactome)	Negative regulation of neuronal death [GO:1901215] Regulation of neuron projection development [GO:0010975]
AKT	PPARGC1A	Arrow	R-HSA-04151 (Reactome)
GAPDH inhibitors	GAPDH	mim-inhibition	CHEBI:70817 (ChEBI)
GAPDH	AKT	mim-stimulation	EBI-7982916 (IntAct)	GAPDH can bind AKT to limit dephosphorylation, prolonging AKT activity and therefor increase mitochondrial membrane potential stabilization [PMID:23645209].
GTP		Arrow	4.6.1.2 (BRENDA)
NOS	GAPDH	Arrow	EBI-10091848 (IntAct)
NOS	Nitric oxide	mim-conversion	1.14.13.39 (BRENDA)	The family of nitric oxide synthases produce nitric oxide (NO) from L-argine, oxigen and NAPDH [PMID:1722402,PMID:1662386].
NRF1	TFAM	mim-transcription-translation	WP3331 (WikiPathways)
Nitric oxide	sGC	mim-binding	R-HSA-392154 (Reactome)	Soluble guanylyl cyclases (sGC) are activated by nitric oxide (NO) [PMID:9742212].
PDE4 inhibitors	PDE4	TBar	CHEBI:68844 (ChEBI)
PDE4	AMP	mim-catalysis	3.1.4.53 (BRENDA)	The family of PDE4s (cAMP-specific 3',5'-cyclic phosphodiesterases) hydrolyse cAMP into AMP.
PDE5		mim-catalysis	3.1.4.35 (BRENDA)	Inhibition of cGMP degradation by PDE5 increases cGMP availability [PMID:9714779].
PPARGC1A	NRF1	mim-transcription-translation	WP3331 (WikiPathways)	Transcriptional coactivator
PRKG1	AKT	Arrow	R-HSA-1257604 (Reactome)
PRKN	ZNF746	Arrow	EBI-3862570 (IntAct)
TFAM	OXPHOS capacity	Arrow	WP3331 (WikiPathways)
ZNF746	PPARGC1A	mim-inhibition	EBI-3989372 (IntAct)	Repressed transcription of PGC-1-alpha (PPARGC1A), thereby playing a role in regulation of neuron death [PMID:21376232]
cGMP		Arrow	2.7.11.12 (BRENDA)
cGMP	GMP	mim-conversion	3.1.4.35 (BRENDA)	cGMP is converted into GMP through hydrolysis by PDE5 [PMID:7870041].
cGMP	Smooth muscle relaxation	Arrow	R-HSA-418457 (Reactome)	An increase in cGMP leads to smooth muscle relaxation and therefore relieve the symptoms of erectile disfunction [PMID:2545495,PMID:8813924].
sGC	PRKG1	Arrow	R-HSA-392154 (Reactome)
sGC		mim-stimulation	4.6.1.2 (BRENDA)	sGCs catalyze the conversion of GTP into GMP.
sildenafil	PDE5	TBar	DB00203 (DrugBank)
tideglusib	GSK3B	TBar	DB12129 (DrugBank)	Glycogen synthase kinase 3beta (GSK3beta) tideglusib (NP031112) has anti-inflammatory and neuroprotective properties [PMID:17522320].